Almac Pharma Services LLC

Form 483 issued February 3, 2022 · Audubon, Pennsylvania

Inspection
Jan 19 – Feb 3, 2022
Investigator
Brandy N. Lepage
Observations
2
Pages
4
FEI number
3000214934

In short: On February 3, 2022, FDA issued a Form 483 with 2 observations to Almac Pharma Services LLC in Audubon, Pennsylvania (FEI 3000214934) after an inspection that ran Jan 19 – Feb 3, 2022. The investigator was Brandy N. Lepage. Most observations concern quality system and facilities & equipment; the most-cited regulation is 21 CFR 211.58 (maintenance).

At a glance

Quality system and facilities & equipment account for 2 of 2 observations.

Quality system1
Facilities & equipment1

Most cited: 21 CFR 211.192 (1×) · 211.58 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

  2. 02

    Deviations from written production and process control…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Almac Pharma Services LLC?

FDA listed 2 observations on this Form 483, mostly about quality system and facilities & equipment. The most-cited regulation is 21 CFR 211.58 (maintenance). The opening words of each observation are shown on this page.

Who inspected Almac Pharma Services LLC?

Brandy N. Lepage is named on this Form 483, for the inspection of Jan 19 – Feb 3, 2022. Each investigator has a profile showing what they cite most.

When was Almac Pharma Services LLC inspected by FDA?

The inspection ran Jan 19 – Feb 3, 2022, and the Form 483 is dated February 3, 2022.

How do I get the full Form 483 for Almac Pharma Services LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free